Clinical Chemistry Conference - Medlab Middle East Congress

Clinical Chemistry Conference

5.25 CME Credits

Live & in-person

8 February 2023

Dubai World Trade Centre

Clinical Chemistry Conference

5.25 CME Credits


Overview:

 

Post -pandemic, Clinical Chemists must be on the leading-edge of laboratory operation and  Clinical Chemistry track will bring timely topics on lessons of the pandemic, delivering  healthcare in new ways and the evolving clinical needs for POCT 

Key topics:

 

  • Pathogenesis and laboratory diagnosis of cardiometabolic syndrome 
  • Biomarkers of alcohol use and misuse; CDT and others 
  • New insights in vitamin D – functional vitamin D deficiency 
  • Hyperautomation for clinical laboratories 
  • Transforming laboratory medicine through mobile technologies 

Benefits of attending:

 

  • Evaluate the impact of digital technologies on point-of-care diagnostics 
  • Discuss updates on vitamin D deficiency status 
  • Review the Glucose Tolerance Test 
  • Assess total, adjusted and ionized calcium in hospitalized patients 

 

Chairs:

 

  • Dr Fayha Ahmed, Consultant and Head of Biochemistry Unit, Pathology & Genetics Department, Dubai Hospital, Dubai, UAE
  • Dr Laila AbdelWareth, Acting Executive Director, National Reference Laboratory (NRL); Chair, Pathology & Laboratory Medicine Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE 

 

Activity Director:  

 

  • Dr Ziad Peerwani, Medical Director, Cleveland Clinic Laboratories, Pathology & Laboratory Medicine Institute-PLMI, Cleveland Clinic, Cleveland, Ohio, USA 

Speakers:

 

  • Dr Anwar Borai, Associate Professor Clinical Biochemistry, Director Clinical Laboratory Sciences Program, College of Applied Medical Sciences, King Saudi Bin Abdulaziz University for Health Sciences (KSAU-HS); Clinical Scientist, Section Head, Clinical Biochemistry, King Abdulaziz Medical City, Jeddah, KSA
  • Prof Damien Gruson, Head - Department of Clinical Biochemistry, Cliniques Universitaires Saint Luc, Brussels, Belgium 
  • Prof James H. Nichols, Professor of Pathology, Microbiology, and Immunology; Medical Director of Clinical Chemistry and Point-of-Care Testing; Vanderbilt University Medical Center, Nashville, Tennessee, USA 
  • Prof Khosrow Adeli, President, International Federation of Clinical Chemistry and Laboratory Medicine (IFCC); Head and Professor, Clinical Biochemistry, Paediatric Laboratory Medicine; Senior Scientist, Molecular Medicine, Research Institute, The Hospital for Sick Children/University of Toronto, Toronto, Ontario, Canada
  • Prof. Dr Markus Herrmann, Chair of Institute, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria 
  • Dr Nafila Bazdawi Al-Riyami, Senior Consultant Medical Biochemist, Deputy HOD, Dept of Biochemistry, Sultan Qaboos University Hospital; Associate Program Director, Oman Medical Specialty Board, Seeb, Oman
  • Reenita Das, Healthcare and Life Sciences Partner and Senior Vice President, Frost & Sullivan, Dubai, UAE
  • Prof Riad Bayoumi, Chaiman - Basic Medical Sciences, Mohammed Bin Rashid University of Medicine, and Health Sciences (MBRU), Dubai, UAE 
  • Dr Shereen Atef, Consultant Clinical Pathologist, NRL & Imperial College London Diabetes Centre (ICLDC), Abu Dhabi, UAE